BSW Wealth Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Sell
6,431
-1,702
-21% -$76.1K 0.03% 271
2026
Q1
$392K Buy
8,133
+2,466
+44% +$115K 0.05% 204
2025
Q4
$275K Sell
5,667
-2,409
-30% -$119K 0.03% 262
2025
Q3
$381K Buy
8,076
+341
+4% +$16.5K 0.05% 212
2025
Q2
$374K Sell
7,735
-378
-5% -$19.3K 0.05% 207
2025
Q1
$450K Buy
+8,113
New +$439K 0.07% 169
2024
Q3
Sell
-5,612
Closed -$272K 330
2024
Q2
$272K Buy
5,612
+38
+0.7% +$1.83K 0.04% 229
2024
Q1
$271K Buy
+5,574
New +$272K 0.05% 236
2021
Q3
Sell
-4,215
Closed -$222K 268
2021
Q2
$222K Buy
+4,215
New +$220K 0.06% 219

Other funds holding SNY

BSW Wealth Partners's SNY Position: Q2 2026 in Review

BSW Wealth Partners reduced its Sanofi (SNY) stake by 21% in Q2 2026, selling an estimated $76.1K and leaving 6,431 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #271.

BSW Wealth Partners first reported a position in SNY in Q2 2021 and has held it in 9 quarters since. The position peaked at $450K in Q1 2025. 109 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • BSW Wealth Partners held 6,431 shares of Sanofi worth $274K as of Q2 2026.
  • BSW Wealth Partners sold 1,702 Sanofi shares in Q2 2026, an estimated $76.1K.
  • Sanofi made up 0.03% of BSW Wealth Partners's portfolio in Q2 2026, its #271 holding.
  • BSW Wealth Partners first reported a position in Sanofi in Q2 2021 and has held it in 9 quarters since.
  • BSW Wealth Partners's Sanofi position peaked at $450K in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on BSW Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.